مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

351
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

238
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EFFECTS OF ANTIVIRAL THERAPY ON THE RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER CURATIVE RESECTION OR LIVER TRANSPLANTATION

Pages

  0-0

Abstract

 Context: HEPATOCELLULAR CARCINOMA (HCC) is a fatal disease. Chronic hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infection is the major cause of HCC. High viral replication rate and related hepatic/systematic inflammation are the major risk factors in HCC RECURRENCE after hepatectomy or liver transplantation.Evidence Acquisition: Some of the carcinogenesis-related HBV mutations are also associated with poor prognosis for HCC patients. Antiviral therapy is an option for improving HCC prognosis after surgery. In case of HBV-associated HCC, treatment with interferon and nucleos (t) ide analogues (NAs), especially interferon, is effective in improving the prognosis. However, long-term use of NAs increases the possibility of developing drug-resistant viral mutations such as the HBV rtA181T/sW172 mutation, which increases the risk of HCC RECURRENCE.Results: In cases of HCV-associated HCC, standard interferon with or without ribavirin therapy is effective in improving the prognosis of HCV-associated HCC; however, some HCV mutations, such as the amino acid substitution M91L, are associated with treatment failure and a poor prognosis. Therapeutic efficacy needs to be confirmed using largescale, randomized, placebo-controlled clinical trials.Conclusions: Surveillance of viral mutations during antiviral treatment and a better understanding of the associations of HCC RECURRENCE with viral load, inflammation-associated signaling, and environmental factors can aid the development of more effective strategies for the prevention of HCC RECURRENCE after surgery.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    DU, YAN, SU, TONG, DING, YIBO, & CAO, GUANGWEN. (2012). EFFECTS OF ANTIVIRAL THERAPY ON THE RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER CURATIVE RESECTION OR LIVER TRANSPLANTATION. HEPATITIS MONTHLY, 12(10), 0-0. SID. https://sid.ir/paper/306809/en

    Vancouver: Copy

    DU YAN, SU TONG, DING YIBO, CAO GUANGWEN. EFFECTS OF ANTIVIRAL THERAPY ON THE RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER CURATIVE RESECTION OR LIVER TRANSPLANTATION. HEPATITIS MONTHLY[Internet]. 2012;12(10):0-0. Available from: https://sid.ir/paper/306809/en

    IEEE: Copy

    YAN DU, TONG SU, YIBO DING, and GUANGWEN CAO, “EFFECTS OF ANTIVIRAL THERAPY ON THE RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER CURATIVE RESECTION OR LIVER TRANSPLANTATION,” HEPATITIS MONTHLY, vol. 12, no. 10, pp. 0–0, 2012, [Online]. Available: https://sid.ir/paper/306809/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button